|« Previous month||Next month »|
28-Apr-2011 - Royal DSM NV says its pharmaceutical contract manufacturing business model is ‘out of step with market needs’ after the unit’s Q1 performance blots an otherwise positive set of financials.
28-Apr-2011 - Switzerland – based specialty chemicals group Clariant has acquired 96.15 per cent of German Süd – Chemie.
28-Apr-2011 - Becton, Dickinson and company (BD) has announced that production of its Hypak prefilled in Japan will resume later this year as operations in the country are recovering faster than expected.
28-Apr-2011 - US drug developer, PharmStar Pharmaceuticals, has reached an agreement to buy a new 24,000 square foot manufacturing facility in Wilson, North Carolina.
28-Apr-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at DSM, Mersana and Diamyd Medical.
27-Apr-2011 - The finding that space flight is detrimental to drug stability may have implications for drug packaging, dispensing technologies and mail order delivery according to a NASA study.
27-Apr-2011 - The United States Pharmacopeial Convention (USP) and the Chinese Pharmacopoeia Commission (ChP) have made mutual executive appointments in an effort to further align drug quality standards.
27-Apr-2011 - Oystar has sold its processing tech units, Huttlin and Manesty, to Bosch in a deal that continues its effort to refocus on primary and secondary packaging.
27-Apr-2011 - Pharma giant Eli Lilly and medical device maker Medtronic are to collaborate on the research and development of an implantable drug delivery system for the treatment of Parkinson’s disease.
27-Apr-2011 - Teva has resumed production at its Irvine, California plant a year after quality control issues put production on hold.
26-Apr-2011 - Bio-Rad has launched what it claims is the drug industry’s first all in one chromatrography platform for small-scale biopharmaceutical manufacturing.
26-Apr-2011 - Tablet testing tech specialist Sotax has set up a new unit in India in the first stage of a five year plan to expand its business in the country.
26-Apr-2011 - US-based vaccine specialist, Caliber Biotherapeutics, has opened the world’s largest modular, plant-made pharmaceutical manufacturing facility at its headquarters in Bryan, Texas.
26-Apr-2011 - Biogen Idec and Merck & Co are expanding capabilities and adding jobs in Durham, North Carolina, US.
21-Apr-2011 - Gilead has entered into a licence and collaboration agreement with drug delivery specialists MicroDose Therapeutx to develop a treatment for respiratory syncytial virus (RSV).
21-Apr-2011 - China-based Hebei Aoxing is to produce naloxone hydrochloride API after it successfully adopted new drug processing technology.
21-Apr-2011 - Industrial PC supplier Noax says pharmaceutical industry demand for sealed computers is growing and being driven by increasing regulatory focus on containment in manufacturing processes.
21-Apr-2011 - US-based chemical services provider Doe and Ingalls has renewed and expanded its partnership with BioVectra.
20-Apr-2011 - Ireland-based Warner Chilcott is to axe 500 European jobs as it deals with the fallout from the patent expiry of its osteoporosis drug, Actonel.
20-Apr-2011 - Pharma, distributors and dispensers have all called for a single, US-wide track-and-trace standard that pre-empts state laws.
20-Apr-2011 - Sartorius Stedim Biotech has launched a handheld device to aseptically cut and seal silicone tubing after fluid transfer.
20-Apr-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Raptor, Regulus, Novavax and Symphogen.
19-Apr-2011 - US-based tissue regeneration specialist, Organogensis, has broken ground on the construction of the world’s largest automated living cell manufacturing plant in Canton, Massachusetts.
19-Apr-2011 - The IFPMA has welcomed a WHO proposal to fund creation of extra vaccine production capacity to cope with global influenza epidemics.
19-Apr-2011 - Continuous manufacturing offers significant advantages for drug production in terms of quality and efficiency, but more research and regulatory input is needed to help the pharmaceutical sector reap the benefits...
|« Previous month||Next month »|